We are live on ! Find out more
VXRT

Vaxart

Delisted

VXRT was delisted on the 7th of July, 2025.

98 hedge funds and large institutions have $10.3M invested in Vaxart in 2025 Q2 according to their latest regulatory filings, with 17 funds opening new positions, 20 increasing their positions, 18 reducing their positions, and 10 closing their positions.

New
Increased
Maintained
Reduced
Closed

1,067% more call options, than puts

Call options by funds: $35K | Put options by funds: $3K

70% more first-time investments, than exits

New positions opened: 17 | Existing positions closed: 10

11% more repeat investments, than reductions

Existing positions increased: 20 | Existing positions reduced: 18

7% more funds holding

Funds holding: 9298 (+6)

1.99% less ownership

Funds ownership: 11.98%9.99% (-2%)

7% less capital invested

Capital invested by funds: $11.1M → $10.3M (-$809K)

Holders
98
Holders Change
+6
Holders Change %
+6.52%
% of All Funds
1.29%
Holding in Top 10
Holding in Top 10 Change
Holding in Top 10 Change %
% of All Funds
New
17
Increased
20
Reduced
18
Closed
10
Calls
$35K
Puts
$3K
Net Calls
+$32K
Net Calls Change
+$27K

VXRT Hedge Fund Activity: Q2 2025 in Review

98 of the 7,596 institutional investors tracked by Wall St. Rank reported a position in Vaxart (VXRT) for Q2 2025, worth a combined $10.3M — down 7.3% from $11.1M a quarter earlier.

Buyers outnumbered sellers: 17 funds opened new VXRT positions and 10 closed out — a net gain of 7 holders — while 20 added to existing stakes and 18 trimmed.

The largest buyer was Marshall Wace, opening a new position worth an estimated $767K. The largest seller was Sio Capital Management, exiting entirely with an estimated $2.27M sold.

  • 98 institutional investors held Vaxart (VXRT) as of Q2 2025, up from 92 in Q1 2025.
  • Funds reported $10.3M of Vaxart stock for Q2 2025, down 7.3% quarter-over-quarter.
  • 17 funds opened new Vaxart positions in Q2 2025 and 10 closed out, a net change of +7 holders.
  • The largest Vaxart buyer in Q2 2025 was Marshall Wace, an estimated $767K added.
  • The largest Vaxart seller in Q2 2025 was Sio Capital Management, an estimated $2.27M sold.

Based on aggregated 13F filings for Q2 2025.